Bleeding complications of thromboprophylaxis with dabigatran, nadroparin or rivaroxaban for 6 weeks after total knee arthroplasty surgery: a randomised pilot study.
Lucia van der VeenMarijn SegersJos Jam van RaayCarina LE Gerritsma-BleekerReinoud W BrouwerNic Jgm VeegerMarinus H van HulstPublished in: BMJ open (2021)
NCT01431456.
Keyphrases
- atrial fibrillation
- direct oral anticoagulants
- venous thromboembolism
- minimally invasive
- coronary artery bypass
- clinical trial
- open label
- double blind
- study protocol
- percutaneous coronary intervention
- pain management
- risk factors
- surgical site infection
- placebo controlled
- pulmonary embolism
- randomized controlled trial
- coronary artery disease